Sofia Lampaki

1.7k total citations
62 papers, 1.2k citations indexed

About

Sofia Lampaki is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Sofia Lampaki has authored 62 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 20 papers in Surgery and 19 papers in Oncology. Recurrent topics in Sofia Lampaki's work include Pleural and Pulmonary Diseases (19 papers), Lung Cancer Treatments and Mutations (11 papers) and Trauma Management and Diagnosis (9 papers). Sofia Lampaki is often cited by papers focused on Pleural and Pulmonary Diseases (19 papers), Lung Cancer Treatments and Mutations (11 papers) and Trauma Management and Diagnosis (9 papers). Sofia Lampaki collaborates with scholars based in Greece, United States and Germany. Sofia Lampaki's co-authors include Paul Zarogoulidis, Ioannis Kioumis, Georgia Pitsiou, Antonis Papaiwannou, Nikolaos Katsikogiannis, Ioannis Mpoukovinas, George Lazaridis, Vasilios Karavasilis, Kosmas Tsakiridis and Haidong Huang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Sofia Lampaki

61 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofia Lampaki Greece 23 640 361 200 187 88 62 1.2k
Alexander Gelbard United States 21 966 1.5× 284 0.8× 345 1.7× 208 1.1× 59 0.7× 104 1.7k
Seokjin Haam South Korea 20 489 0.8× 667 1.8× 176 0.9× 130 0.7× 134 1.5× 101 1.2k
Aggeliki Rapti Greece 20 717 1.1× 167 0.5× 283 1.4× 158 0.8× 66 0.8× 73 1.1k
Patricia R. Chess United States 22 859 1.3× 453 1.3× 89 0.4× 272 1.5× 48 0.5× 52 1.5k
Monther Bajbouj Germany 24 847 1.3× 1.6k 4.4× 430 2.1× 329 1.8× 116 1.3× 77 2.3k
Kaid Darwiche Greece 17 461 0.7× 115 0.3× 163 0.8× 108 0.6× 74 0.8× 35 755
Richard W. Kim United States 14 328 0.5× 283 0.8× 246 1.2× 579 3.1× 85 1.0× 25 1.6k
Samjot S. Dhillon United States 20 539 0.8× 222 0.6× 145 0.7× 198 1.1× 90 1.0× 71 1.1k
Kalpaj R. Parekh United States 23 669 1.0× 763 2.1× 152 0.8× 217 1.2× 116 1.3× 90 1.5k
Franz‐Xaver Schmid Germany 17 416 0.7× 265 0.7× 86 0.4× 340 1.8× 319 3.6× 42 1.1k

Countries citing papers authored by Sofia Lampaki

Since Specialization
Citations

This map shows the geographic impact of Sofia Lampaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Lampaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Lampaki more than expected).

Fields of papers citing papers by Sofia Lampaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Lampaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Lampaki. The network helps show where Sofia Lampaki may publish in the future.

Co-authorship network of co-authors of Sofia Lampaki

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Lampaki. A scholar is included among the top collaborators of Sofia Lampaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Lampaki. Sofia Lampaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Groen, Harry J.M., Maarten J. Postma, Εleftherios Ζervas, et al.. (2025). Lung cancer screening with volume computed tomography is cost-effective in Greece. PLoS ONE. 20(3). e0316351–e0316351. 1 indexed citations
2.
Domvri, Kalliopi, Alexey V. Yaremenko, Savvas Petanidis, et al.. (2024). Expression patterns and clinical implications of PDL1 and DLL3 biomarkers in small cell lung cancer retrospectively studied: Insights for therapeutic strategies and survival prediction. Heliyon. 10(5). e27208–e27208. 4 indexed citations
3.
4.
5.
Linardou, Helena, G. Kouvatseas, Giannis Mountzios, et al.. (2019). Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment. Cancer Genomics & Proteomics. 16(6). 531–541. 11 indexed citations
6.
Lampaki, Sofia, et al.. (2017). P3.02c-101 Immunotherapy with Nivolumab in NSCLC Patients: One Centre Preliminary Results. Journal of Thoracic Oncology. 12(1). S1341–S1341. 1 indexed citations
7.
Domvri, Kalliopi, Paul Zarogoulidis, Κonstantinos Porpodis, et al.. (2015). Could Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?. Journal of Cancer. 6(4). 360–366. 8 indexed citations
8.
Paliouras, Dimitrios, Nikolaos Barbetakis, George Lazaridis, et al.. (2015). Video-assisted thoracic surgery and pneumothorax.. Europe PMC (PubMed Central). 7(Suppl 1). S56–61. 5 indexed citations
9.
Lampaki, Sofia. (2015). 033. Defining the role of tyrosine kinase inhibitors in early stage non-small cell lung cancer. Journal of Thoracic Disease. 7(1). 2 indexed citations
10.
Lazaridis, George, Sofia Baka, Ioannis Mpoukovinas, et al.. (2015). Postoperative pain management.. PubMed. 7(Suppl 1). S62–72. 40 indexed citations
11.
Boutsikou, Efimia, et al.. (2015). Cox-2 inhibitors in the treatment of small cell lung cancer patients. OA268–OA268. 2 indexed citations
12.
Pitsiou, Georgia, Ioannis Kioumis, Paul Zarogoulidis, et al.. (2015). Prophylactic antibiotic administration for post cardiothoracic surgery sternal wounds: a retrospective study.. PubMed. 3(4). 56–56. 1 indexed citations
13.
Zarogoulidis, Paul, Kalliopi Domvri, Κonstantinos Porpodis, et al.. (2015). Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients. International Journal of COPD. 10. 1123–1123. 5 indexed citations
14.
Baltayiannis, Nikolaos, George Lazaridis, Dimitrios Anagnostopoulos, et al.. (2015). Minimally invasive procedures.. PubMed. 3(4). 55–55. 5 indexed citations
15.
Zarogoulidis, Paul, Κonstantinos Porpodis, Ioannis Kioumis, et al.. (2014). Stem cells’ guided gene therapy of cancer: New frontier in personalized and targeted therapy. PubMed. 2(1). 22–33. 16 indexed citations
16.
Zarogoulidis, Paul, Kosmas Tsakiridis, Sofia Lampaki, et al.. (2014). Use of Proteins as Biomarkers and Their Role in Carcinogenesis. Journal of Cancer. 6(1). 9–18. 43 indexed citations
17.
Manika, Κaterina, Ioannis Kioumis, Paul Zarogoulidis, et al.. (2014). Pneumothorax in sarcoidosis.. PubMed. 6(Suppl 4). S466–9. 22 indexed citations
18.
Zarogoulidis, Paul, Wolfgang Hohenforst‐Schmidt, Haidong Huang, et al.. (2014). A gene therapy induced emphysema model and the protective role of stem cells. Diagnostic Pathology. 9(1). 195–195. 3 indexed citations
19.
Organtzis, John, Sofia Lampaki, Paul Zarogoulidis, et al.. (2014). Phosphodiesterase (PDE)-4 Inhibitors and COPD Correlation with Cancer. Journal of Cancer. 5(8). 625–627. 1 indexed citations
20.
Televantou, Despina, George Karkavelas, Prodromos Hytiroglou, et al.. (2012). DARPP32, STAT5 and STAT3 mRNA Expression Ratios in Glioblastomas are Associated with Patient Outcome. Pathology & Oncology Research. 19(2). 329–343. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Gelbard Breakdown of academic impact, for papers by Seokjin Haam Breakdown of academic impact, for papers by Aggeliki Rapti Breakdown of academic impact, for papers by Patricia R. Chess Breakdown of academic impact, for papers by Monther Bajbouj Breakdown of academic impact, for papers by Kaid Darwiche Breakdown of academic impact, for papers by Richard W. Kim Breakdown of academic impact, for papers by Samjot S. Dhillon Breakdown of academic impact, for papers by Kalpaj R. Parekh Breakdown of academic impact, for papers by Franz‐Xaver Schmid
Rankless by CCL
2026